The risk of myelodysplastic syndrome and acute myeloid leukemia by metformin use and type 2 diabetes status - a Danish nation-wide cohort study.
作者信息
Aziz Umar
机构信息
Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan.
出版信息
Acta Oncol. 2025 Jul 2;64:857-858. doi: 10.2340/1651-226X.2025.44082.
Abstract
摘要
相似文献
1
The risk of myelodysplastic syndrome and acute myeloid leukemia by metformin use and type 2 diabetes status - a Danish nation-wide cohort study.二甲双胍使用及2型糖尿病状态与骨髓增生异常综合征和急性髓系白血病的风险——一项丹麦全国队列研究
Acta Oncol. 2025 Jul 2;64:857-858. doi: 10.2340/1651-226X.2025.44082.
2
Bexmarilimab plus azacitidine for high-risk myelodysplastic syndrome and relapsed or refractory acute myeloid leukaemia: results from the dose-escalation part of a multicentre, single-arm, phase 1/2 trial.贝克斯马里单抗联合阿扎胞苷治疗高危骨髓增生异常综合征及复发或难治性急性髓系白血病：一项多中心、单臂、1/2期试验剂量递增部分的结果
Lancet Haematol. 2025 May 28. doi: 10.1016/S2352-3026(25)00103-6.
4
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.2型糖尿病患者使用二甲双胍时发生致命性和非致命性乳酸性酸中毒的风险。
Cochrane Database Syst Rev. 2002(2):CD002967. doi: 10.1002/14651858.CD002967.
5
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.2型糖尿病患者使用二甲双胍发生致命性和非致命性乳酸性酸中毒的风险。
Cochrane Database Syst Rev. 2003(2):CD002967. doi: 10.1002/14651858.CD002967.
6
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.2型糖尿病患者使用二甲双胍发生致命性和非致命性乳酸性酸中毒的风险。
Cochrane Database Syst Rev. 2006 Jan 25(1):CD002967. doi: 10.1002/14651858.CD002967.pub2.
7
The risk of myelodysplastic syndrome and acute myeloid leukemia by metformin use and type 2 diabetes status - a Danish nation-wide cohort study.二甲双胍使用及2型糖尿病状态与骨髓增生异常综合征和急性髓系白血病的风险——一项丹麦全国队列研究
Acta Oncol. 2025 May 7;64:623-629. doi: 10.2340/1651-226X.2025.42422.
9
Metformin Use and Age-Related Macular Degeneration in Patients Without Diabetes.非糖尿病患者使用二甲双胍与年龄相关性黄斑变性
JAMA Ophthalmol. 2024 Jan 1;142(1):53-57. doi: 10.1001/jamaophthalmol.2023.5478.
10
Prevalent Metformin Use in Adults With Diabetes and the Incidence of Long COVID: An EHR-Based Cohort Study From the RECOVER Program.在糖尿病成人中普遍使用二甲双胍与长新冠的发病率：来自 RECOVER 计划的基于电子健康记录的队列研究。
Diabetes Care. 2024 Nov 1;47(11):1930-1940. doi: 10.2337/DCa24-0032.
本文引用的文献
1
The risk of myelodysplastic syndrome and acute myeloid leukemia by metformin use and type 2 diabetes status - a Danish nation-wide cohort study.二甲双胍使用及2型糖尿病状态与骨髓增生异常综合征和急性髓系白血病的风险——一项丹麦全国队列研究
Acta Oncol. 2025 May 7;64:623-629. doi: 10.2340/1651-226X.2025.42422.
2
Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England.降糖治疗处方与 2 型糖尿病患者 COVID-19 死亡率的关系：英国全国性观察研究。
Lancet Diabetes Endocrinol. 2021 May;9(5):293-303. doi: 10.1016/S2213-8587(21)00050-4. Epub 2021 Mar 30.
Zotero 插件